Cancer research is growing. The population of skilled pathologists is shrinking.
Is Smarter Testing the answer?
With demand for pathological services in clinical trials on the rise and anatomic pathologists in increasingly short supply, access to pathologists in disease subspecialties has never been more critical.
In response, ACM Global Laboratories has developed Smarter Testing™ for Oncology to deliver a unique service offering for clients conducting cancer research.
The Smarter Testing for Oncology includes four key elements:
A Smarter Testing approach. By determining the classification of the cancer, understanding the variants in the patient, the effectiveness of a drug on a particular tumor and the markers or stains being looked at, our team ensures the most appropriate and cost-effective tests are chosen for the desired outcome and that critical trial milestones are feasible.